Publication | Open Access
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
17
Citations
34
References
2021
Year
ClinicalTrials.gov, identifier: NCT03579082.
| Year | Citations | |
|---|---|---|
Page 1
Page 1